Received Sep 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | Z7L7H | — |
one year 10 month old male patient with initials empty was accidentally given a TDAP dose, which was supposed to be a DTAP dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 22-month-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number Z7L7H, expiry date 09-AUG-2026) for prophylaxis. Co-suspect products included DTPa (DTaP vaccine) for prophylaxis. On 21-JUL-2025, the patient received the 1st dose of Boostrix. The patient did not receive DTaP vaccine. On 21-JUL-2025, an unknown time after receiving Boostrix the patient experienced wrong vaccine administered (Verbatim: one year 10 month old male patient with initials empty was accidentally given a TDAP dose, which was supposed to be a DTAP dose). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 05-AUG-2025 The practice manager reported that a patient of inappropriate age was accidentally given a TDAP dose (Boostrix), which was supposed to be a DTAP dose, being the 4th dose in the series, which led to wrong vaccine administered. The reporter wanted to know how to proceed. The Vaccine Administration Facility was the same as primary reporter.